{"id":"NCT03687372","sponsor":"Aclaris Therapeutics, Inc.","briefTitle":"Study of A-101 Topical Solution for the Treatment of Common Warts","officialTitle":"A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-09-17","primaryCompletion":"2019-06-20","completion":"2019-09-06","firstPosted":"2018-09-27","resultsPosted":"2020-10-05","lastUpdate":"2020-10-05"},"enrollment":503,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Common Wart"],"interventions":[{"type":"DRUG","name":"A-101","otherNames":["hydrogen peroxide 45%"]},{"type":"OTHER","name":"vehicle","otherNames":["isopropyl alcohol and sterile water"]}],"arms":[{"label":"A-101","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"OTHER"}],"summary":"A Phase 3 Study of A-101 Topical Solution Applied Twice a Week in Subjects with Common Warts","primaryOutcome":{"measure":"The Primary Efficacy Endpoint is the Number of Subjects Whose Identified Common Warts Are Determined to be Clear on the PWA Scale (PWA=0) at Visit 10 (Day 60)","timeFrame":"Day 60","effectByArm":[{"arm":"Hydrogen Peroxide 45% A-101","deltaMin":40,"sd":null},{"arm":"Isopropyl Alcohol and Water Vehicle","deltaMin":13,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0003"}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":24,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":254},"commonTop":["Application site pain","Application site scab","Application site erythema","Application site pruritus","Nasopharyngitis"]}}